Henning Willers, MD
Lab Co-Director, Associate Professor
“I have been a PI in this lab since 2005. Over the years, our interests have shifted somewhat away from DNA repair mechanisms and assays to modeling in the lab the tumor heterogeneity that impacts treatment responses in the clinic. We have grown especially fond of KRAS, EGFR, and PARP all of which are important in lung cancer.”


Qingyuan (Emma) Yang, PhD
Postdoctoral Fellow
“My main interest is in predictive biomarkers and mechanisms of variable sensitivity to proton radiation that we see in cancers. I am also interested in FLASH radiation and targeted radiosensitizers.”




Xiao Pan, PhD
Postdoctoral Fellow
“My main interest is in screening and validating of molecular targeted radiosensitizers. In collaboration with the MGH Center for Molecular Therapeutics, I am involved in high-throughput drug screening across a panel of ~100 annotated cancer cell lines using 3D formats. An important goal of ours is to identify predictive genomic biomarkers for several of these sensitizers.”


Liliana Gheorghiu, MS
Senior Research Technologist
“I am involved in managing the Willers lab as well as providing experimental input. One of my aims is to study radiosensitization by analyzing DNA repair responses after drug/X-ray vs X-ray alone treatments in ex vivo human tumor explants.”




Aliza Rosenkranz, BS
Lab Technician
“I graduated from the University of Vermont in 2020 with a degree in Biological Science. In the lab, I focus on studying combinations of a KRAS targeted small molecule inhibitor and radiation in lung cancer.”




Comments are closed.